Okyo Pharma News Today

OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 50,800 shares, a drop of 21.4% from the February 29th total of 64,600 shares. Based on an average daily trading volume, of 183,100 shares, the short-interest ratio is presently […]

OKYO Pharma (NASDAQ:OKYO – Free Report) had its target price upped by HC Wainwright from $6.00 to $7.00 in a research note published on Friday morning, Benzinga reports. The firm currently has a buy rating on the stock. OKYO Pharma Stock Performance OKYO Pharma stock opened at $1.46 on Friday. OKYO Pharma has a 12 […]

OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) shares traded down 2.8% during mid-day trading on Monday . The stock traded as low as $1.50 and last traded at $1.54. 10,264 shares changed hands during trading, a decline of 89% from the average session volume of 89,761 shares. The stock had previously closed at $1.59. […]

OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) saw a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 78,100 shares, a decline of 35.6% from the October 15th total of 121,200 shares. Based on an average daily trading volume, of 258,000 shares, the days-to-cover […]

The FTSE 100 company revealed earnings had taken a £30million hit from adverse foreign exchange movements and a £50million impact from customer-friendly sports results.

OKYO Pharma Limited (NASDAQ:OKYO – Get Free Report) was the target of a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 86,500 shares, a drop of 40.8% from the September 15th total of 146,000 shares. Currently, 0.5% of the shares of the company are […]

They climbed 22.7 per cent to 846.4p by the early afternoon, making them one of the top ten performers on the AIM All-Share Index and recovering much of their late September slump.

They climbed 22.7 per cent to 846.4p by the early afternoon, making them one of the top ten performers on the AIM All-Share Index and recovering much of their late September slump.

The polling organisation, known for its close association with British politics, said it had agreed a facility of up to €280million with lenders.

Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares rose 38.7% to $0.1713 in pre-market trading. Shares of Avalo Therapeutics jumped over 45% on Tuesday after the company agreed to divest AVTX-800 series.